Literature DB >> 19383234

In vitro differentiation of human placenta-derived adherent cells into insulin-producing cells.

N Z Sun1, H S Ji.   

Abstract

This study investigated the differentiation of placenta-derived adherent cells (PDACs) into insulin-producing cells (IPCs). PDACs were cultured and the cells characterized by analysis of cell surface markers using flow cytometry. The PDACs were then treated with induction media containing basic fibroblast growth factor (bFGF) and beta-mercaptoethanol (beta-ME). After induction, the presence of IPCs was demonstrated using dithizone staining, and the production of functional insulin was confirmed using immunocytochemistry and an enzyme-linked immunosorbent assay. Expression of the islet-associated genes PDX-1, Insulin 1, Insulin 2 and Glut 2 in the induced cells was measured using a reverse transcription-polymerase chain reaction; PDX-1 was expressed after 7 days of induction and PDX-1, Insulin 1 and Insulin 2 were all detected after 14 days. These results suggest that the placenta could be a new source of stem cells that can be induced to differentiate into IPCs following treatment with media containing bFGF and beta-ME.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19383234     DOI: 10.1177/147323000903700215

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  10 in total

1.  Regulation of mesenchymal stem cell differentiation and insulin secretion by differential expression of Pdx-1.

Authors:  Huijuan Yuan; Hongmei Liu; Rui Tian; Jie Li; Zhigang Zhao
Journal:  Mol Biol Rep       Date:  2012-04-10       Impact factor: 2.316

Review 2.  Wharton's jelly mesenchymal stem cells as candidates for beta cells regeneration: extending the differentiative and immunomodulatory benefits of adult mesenchymal stem cells for the treatment of type 1 diabetes.

Authors:  Rita Anzalone; Melania Lo Iacono; Tiziana Loria; Antonino Di Stefano; Pantaleo Giannuzzi; Felicia Farina; Giampiero La Rocca
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

Review 3.  Modern stem cell therapy: approach to disease.

Authors:  Mateja Zemljic; Bozena Pejkovic; Ivan Krajnc; Lidija Kocbek
Journal:  Wien Klin Wochenschr       Date:  2015-12-10       Impact factor: 1.704

Review 4.  Placental-derived stem cells: Culture, differentiation and challenges.

Authors:  Maira S Oliveira; João B Barreto-Filho
Journal:  World J Stem Cells       Date:  2015-05-26       Impact factor: 5.326

5.  Insulin-producing cells from adult human bone marrow mesenchymal stem cells control streptozotocin-induced diabetes in nude mice.

Authors:  Mahmoud M Gabr; Mahmoud M Zakaria; Ayman F Refaie; Amani M Ismail; Mona A Abou-El-Mahasen; Sylvia A Ashamallah; Sherry M Khater; Sawsan M El-Halawani; Rana Y Ibrahim; Gan Shu Uin; Malgorzata Kloc; Roy Y Calne; Mohamed A Ghoneim
Journal:  Cell Transplant       Date:  2012-06-15       Impact factor: 4.064

6.  Human placenta-derived mesenchymal stem cells and islet-like cell clusters generated from these cells as a novel source for stem cell therapy in diabetes.

Authors:  Sachin Kadam; Sudhakar Muthyala; Prabha Nair; Ramesh Bhonde
Journal:  Rev Diabet Stud       Date:  2010-08-10

7.  In vitro differentiation of human umbilical cord Wharton's jelly mesenchymal stromal cells to insulin producing clusters.

Authors:  Seideh Masoomeh Nekoei; Negar Azarpira; Ladan Sadeghi; Sulmaz Kamalifar
Journal:  World J Clin Cases       Date:  2015-07-16       Impact factor: 1.337

Review 8.  Concise review: mesenchymal stem cells for diabetes.

Authors:  Juan Domínguez-Bendala; Giacomo Lanzoni; Luca Inverardi; Camillo Ricordi
Journal:  Stem Cells Transl Med       Date:  2011-12-07       Impact factor: 6.940

Review 9.  The potential of mesenchymal stem cells derived from amniotic membrane and amniotic fluid for neuronal regenerative therapy.

Authors:  Eun Young Kim; Kyung-Bon Lee; Min Kyu Kim
Journal:  BMB Rep       Date:  2014-03       Impact factor: 4.778

10.  Generation of insulin-producing cells from human bone marrow-derived mesenchymal stem cells: comparison of three differentiation protocols.

Authors:  Mahmoud M Gabr; Mahmoud M Zakaria; Ayman F Refaie; Sherry M Khater; Sylvia A Ashamallah; Amani M Ismail; Nagwa El-Badri; Mohamed A Ghoneim
Journal:  Biomed Res Int       Date:  2014-04-10       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.